Brief: Neurobo Pharmaceuticals Regains Compliance With Nasdaq Minimum Price Requirement
09/01/2024 14:48
Jan 9 (Reuters) - Neurobo Pharmaceuticals Inc NRBO.O :
* NEUROBO PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ
MINIMUM
PRICE REQUIREMENT
Source text for Eikon: ID:nPnb1ZZfta
Further company coverage: NRBO.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on MetaVia
See all newsMetaVia Inc reports results for the quarter ended June 30 - Earnings Summary
MetaVia Q2 net loss widens on higher R&D spending
MetaVia Inc expected to post a loss of 82 cents a share - Earnings Preview
Brief: Biostem Technologies Announces Appointment Of Three New Members To Its Board Of Directors
MetaVia Q1 net loss widens slightly as expenses rise